論文・総説 - 原田　浩之

41. Hideaki Hirai, Naoto Nishii, Yu Oikawa, Toshimitsu Ohsako, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Tohru Ikeda, Hiroyuki Harada. Buccinator muscle invasion is a risk factor for cervical lymph node metastasis in squamous cell carcinoma of the buccal mucosa: A retrospective study. Oncol Lett. 2023.04; 25 (6): 226. ( PubMed, DOI )

42. Okuyama K, Yanamoto S. Oral Bacterial Contributions to Gingival Carcinogenesis and Progression Cancer Prev Res. 2023.04; 16 (4): 199-209. ( PubMed, DOI )

43. Heath BR, Gong W, Taner HF, Broses L, Okuyama K, Cheng W, Jin M, Fitzsimonds ZR, Manousidaki A, Wu Y, Zhang S, Wen H, Chinn SB, Bartee E, Xie Y, Moon JJ, Lei YL. Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING Cell Rep. 2023.04; 42 (4): 112303. ( PubMed, DOI )

44. Atsushi Uesugi, Fumihiko Tsushima, Youji Miyamoto, Hiroyuki Harada. Pollen Food Allergy Syndrome Caused by Japanese Radish: A Case Report. Indian J Dermatol. 2023.02; 68 (1): 123. ( PubMed, DOI )

45. Okuyama K, Suzuki K, Yanamoto S. Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer Cancers. 2023.02; 15 (4): 1111. ( PubMed, DOI )

46. Misako Tanaka, Hiroyuki Harada, Hiroshi Kimura. The role of H3K9me3 in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2023.01; 640 56-63. ( PubMed, DOI )

47. Hirai Hideaki, Kayamori Kou, Noji Rika, Kuroshima Takeshi, Ikeda Tohru, Harada Hiroyuki. 軟口蓋に孤立性の口腔内表在性血管粘液腫が生じた稀な1症例(A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate) Journal of Oral Science. 2023.01; 65 (1): 69-71. ( 医中誌 )

48. Kinoshita N, Tomioka H, Oikawa Y, Fukawa Y, Ikeda T, Harada H. A case of sclerosing odontogenic carcinoma of the mandible with a review of the literature. Journal of oral science. 2023; 65 (4): 281-283. ( PubMed, DOI )

49. Kugimoto T, Yamagata Y, Ohsako T, Hirai H, Nishii N, Kayamori K, Ikeda T, Harada H.. Massive low-grade myxoid liposarcoma of the floor of the mouth: A case report and review of literature. World J Clin Cases. 2022.12; 10 (34): 12742-12749. ( PubMed, DOI )

50. Ohyama Y, Yamashiro M, Michi Y, Uzawa N, Myo K, Sonoda I, Sumino J, Miura C, Mizutani M, Yamamoto D, Kayamori K, Yoda T. Determination of Significant Prognostic Factors for Maxillary Gingival Squamous Cell Carcinoma in 90 Cases Indian J Otolaryngol Head Neck Surg. 2022.12; 74 (3): 5930-5935. ( PubMed, DOI )

51. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model Radiat Res. 2022.12; 198 (6): 632-638. ( PubMed, DOI )

52. Machitani M, Takei J, Kaneko MK, Ueki S, Ohashi H, Watashi K, Kato Y, Masutomi K. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2 Virol J. 2022.12; 19 (1): 213. ( PubMed, DOI )

53. Hirai H, Kayamori K, Noji R, Kuroshima T, Ikeda T, Harada H. A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate. J Oral Sci. 2022.11; 65 (1): 69-71. ( PubMed, DOI )

54. Tsukamoto K, Tanahashi A, Harada H, Takaoka M, Sohara H. Development of a new HotBalloon™ ablation catheter equipped with a balloon surface temperature monitoring sensor for pulmonary vein isolation. J Med Eng Technol. 2022.11; 46 (8): 687-692. ( PubMed, DOI )

55. Nishii N, Hirotsu Y, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer J Oral Maxillofac Surg Med Pathol. 2022.11; 34 (6): 833-841. ( DOI )

56. Nojima H, Kaida A, Kuroshima T, Yoshimura RI, Miura M. Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer Cureus. 2022.11; 14 (11): e31904. ( PubMed, DOI )

57. Nishii Naoto, Hirotsu Yosuke, Takahashi Yukinobu, Takagawa Yuki, Amemiya Kenji, Oyama Toshio, Mochizuki Hitoshi, Furusawa-Nishii Emi, Harada Hiroyuki, Omata Masao. PD-L1陰性の進行口腔癌において好中球・リンパ球比の動的変化を観察することはニボルマブへの治療反応を評価するのに役立つ(Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2022.11; 34 (6): 833-841. ( 医中誌 )

58. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model. Radiat Res. . 2022.10; ( DOI )

59. Takuya Komiyama, Takeshi Kuroshima, Takehito Sugasawa, Shin-Ichiro Fujita, Yuta Ikami, Hideaki Hirai, Fumihiko Tsushima, Yasuyuki Michi, Kou Kayamori, Fumihiro Higashino, Hiroyuki Harada. High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma. Oncol Rep. 2022.10; 48 (4): 183. ( PubMed, DOI )

60. Otsuki Shuya, Hori Ryusuke, Shinohara Shogo, Kojima Tsuyoshi, Tamaki Hisanobu, Asato Ryo, Kitamura Morimasa, Ichimaru Kazuyuki, Kitani Yoshiharu, Kumabe Yohei, Honda Keigo, Tsujimura Takashi, Harada Hiroyuki, Ushiro Koji, Omori Koichi. 再発・転移性頭頸部扁平上皮癌に対するニボルマブ投与患者の実臨床での2年間の長期予後および予後因子(Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck) Auris・Nasus・Larynx. 2022.10; 49 (5): 834-844. ( 医中誌 )